HeartBeam CEO Robert Eno appointed to Board of Directors effective May 5, 2025

HeartBeam, Inc.

CEO Robert Eno joins Board effective May 5, 2025; Board expands from 8 to 9 members.
Eno has 30+ years medtech experience, previously CEO of Preview Medical, leadership at HeartFlow, OptiMedica.
Appointment supports commercialization of HeartBeam's 3D ECG technology; FDA clearance for 3D ECG received Dec 2024.
12-lead ECG Synthesis Software FDA application submitted Jan 2025; Early Access Program underway for clinical feedback.
Executive Chairman cites Eno's go-to-market expertise as key to strategic oversight and growth.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robert Eno

Director

BEAT · HeartBeam, Inc.

Effective: 2025-05-05
Filed: May 5, 2025, 7:59 PM ET

appointed Robert Eno, the Company’s Chief Executive Officer, as a member of the Board effective as of May 5, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Eno was appointed as Director at HeartBeam, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed Robert Eno, the Company’s Chief Executive Officer, as a member of the Board effective as of May 5, 2025

View on SEC.gov

HeartBeam, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-039490

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.